Journal of Cardiovascular Disease Research
Glucose Tolerance Testingin First Episode, Drug Naïve Patients with Schizophrenia
Dr. Tiwari Apurva,Dr. Loya SMitali, Dr. Dubey Vaibhav,Dr. Khan Sumera
JCDR. 2023: 2303-2308
Abstract
Background: Schizophrenia is ranked 8th leading cause of disability adjusted life years (DALY) in the age group between 15 to 44. The DALYs rate in India according to World Health organization was 268.903 per 100,000 residents. Previous studies conducted in antipsychotic naïve patients of schizophrenia suggest that these patients of schizophrenia are already predisposed for developing metabolic syndrome (MetS) and type 2 DM due to the disease itself Aims and objectives: To assess occurrence of impaired glucose tolerance in drug naïve patients with schizophrenia in comparison to normal healthy individuals.
» PDF